US Broker Ratings

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Exploring a 46.71% Potential Upside

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a key player in the healthcare sector specializing in behavioral healthcare services, presents an intriguing opportunity for investors with a potential upside of 46.71%...

HUTCHMED (China) Limited (HCM) Stock Analysis: A Healthcare Innovator with a 71% Potential Upside

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, is gaining significant attention from investors due to its robust pipeline of targeted therapeutics and immunotherapies. With its..

Immunovant, Inc. (IMVT) Stock Report: Exploring a 42.58% Upside Potential in Biotechnology

Immunovant, Inc. (NASDAQ: IMVT), a burgeoning name in the biotech sector, is capturing the attention of investors with its robust pipeline of monoclonal antibodies aimed at treating autoimmune diseases. As..

Perrigo Company plc (PRGO) Stock Analysis: Unpacking the 56% Upside Potential Amidst Volatile Metrics

Perrigo Company plc (NASDAQ: PRGO), a stalwart in the healthcare sector, operates within the specialty and generic drug manufacturing industry. Headquartered in Dublin, Ireland, Perrigo’s expansive portfolio is globally recognized,..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 12.27% Upside Potential Amid Strategic Advancements

Haemonetics Corporation (NYSE: HAE) stands as a notable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.87 billion, this Boston-based company has..

Ultragenyx Pharmaceutical Inc. (RARE)

⚠️ No article content returned.

..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a Biotech Powerhouse with Growth Potential

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands as a prominent player in the biotechnology sector, leveraging its expertise to address rare disorders with innovative solutions. Headquartered in Warren, New Jersey, this..

TransMedics Group, Inc. (TMDX) Stock Analysis: Promising Growth and Robust Ratings Signal Strong Investor Potential

TransMedics Group, Inc. (NASDAQ: TMDX), a leader in medical devices within the healthcare sector, has garnered significant attention from investors due to its innovative approach to organ transplant therapy. Based..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Unpacking the 23% Potential Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is carving out a niche in the biopharmaceutical landscape by targeting rare neuroendocrine diseases with its innovative treatments. With a focus on conditions like POMC..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating a Complex Biotech Landscape with a 7.53 Forward P/E Ratio

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a noteworthy player in the biotechnology sector, focusing on transformative therapies for rare genetic diseases. Despite navigating a challenging market environment, the company..

Alkermes plc (ALKS) Stock Analysis: A Biopharmaceutical Innovator with a 54% Potential Upside

Alkermes plc (NASDAQ: ALKS), a leader in the healthcare sector specializing in drug manufacturing, particularly in specialty and generic pharmaceuticals, has caught the attention of investors with its significant growth..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Volatility with Strategic Partnerships and a Diverse Pipeline

Moderna, Inc. (NASDAQ: MRNA), a leading player in the biotechnology sector, remains at the forefront of medical innovation with its groundbreaking work in messenger RNA (mRNA) medicines. However, the current..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with a 12.42% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a leading player in the biotechnology sector, has been making waves in the healthcare industry with its focus on transformative medicines aimed at treating genetic..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Deep Dive into Its 362% Revenue Growth and Potential Upside

Madrigal Pharmaceuticals, Inc. (MDGL) is capturing the attention of investors with its impressive revenue growth and promising analyst ratings. As a key player in the biotechnology sector, Madrigal focuses on..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a Solid 7.9% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Molina Healthcare Inc (NYSE: MOH) presents an intriguing prospect. With a robust market cap of $8.87 billion, this Long Beach, California-based company..

BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth in the Booming Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) is carving out a significant niche in the healthcare sector, specifically within health information services. With a market capitalization of $6.76 billion, BrightSpring is well-positioned..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unveiling a 15% Potential Upside for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector, is making waves with its recent stock performance and forward-looking potential. As a key player in the medical devices..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Promising Biotech with 137% Upside Potential Awaits Investors

Investors in the biotechnology sector are no strangers to high-risk, high-reward scenarios, and Soleno Therapeutics, Inc. (NASDAQ: SLNO) presents an intriguing opportunity. With a market cap of $2.57 billion and..

Henry Schein, Inc. (HSIC): Exploring Analyst Consensus and Growth Potential in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC), a leader in the healthcare sector, is drawing the attention of investors as a stalwart in the medical distribution industry. With a robust market capitalization..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Unpacking the Upside Potential in Transformative Biotech

In the dynamic world of biotechnology, Akero Therapeutics, Inc. (NASDAQ: AKRO) has been capturing investor attention with its focused strategy on developing groundbreaking treatments for metabolic diseases. Operating out of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds